Outcomes Research in Review

Evaluation of a Digital Intervention for Hypertension Management in Primary Care Combining Self-monitoring of Blood Pressure With Guided Self-management


 

References

The difference in mean cost per patient was £38 (US $51.30, €41.9; 95% CI £27 to £47), which along with the decrease in systolic BP, gave an incremental cost per mm Hg BP reduction of £11 (£6 to £29). Bootstrapping analysis showed the intervention had high (90%) probability of being cost-effective at willingness to pay above £20 per unit reduction. The probabilities of being cost-effective for the intervention against usual care were 87%, 93%, and 97% at thresholds of £20, £30, and £50, respectively.

Conclusion. The HOME BP digital intervention for the management of hypertension by using self-monitored BP led to better control of systolic BP after 1 year than usual care, with low incremental costs. Implementation in primary care will require integration into clinical workflows and consideration of people who are digitally excluded.

Commentary

Elevated BP, also known as hypertension, is the most important, modifiable risk factor for cardiovascular disease and mortality.1 Clinically significant effects and improvements in mortality can be achieved with relatively small reductions in BP levels. Long-established lifestyle modifications that effectively lower BP include weight loss, reduced sodium intake, increased physical activity, and limited alcohol intake. However, motivating patients to achieve lifestyle modifications is among the most difficult aspects of managing hypertension. Importantly, for individuals taking antihypertensive medication, lifestyle modification is recommended as adjunctive therapy to reduce BP. Given that target blood pressure levels are reached for less than half of adults, novel interventions are needed to improve BP control – in particular, individualized cognitive behavioral interventions are more likely to be effective than standardized, single-component interventions.

Guided self-management for hypertension as part of systematic, planned care offers the potential for improvements in adherence and in turn improved long-term patient outcomes.2 Self-management can encompass a wide range of behaviors in addition to medication titration and monitoring of symptoms, such as individuals’ ability to manage physical, psychosocial and lifestyle behaviors related to their condition.3 Digital interventions leveraging apps, software, and/or technologies in particular have the potential to support people in self-management, allow for remote monitoring, and enable personalized and adaptive strategies for chronic disease management.4-5 An example of a digital intervention in the context of guided self-management for hypertension can be a web-based program delivered by computer or phone that combines health information with decision support to help inform behavior change in patients and remote monitoring of patient status by health professionals. Well-designed digital interventions can effectively change patient health-related behaviors, improve patient knowledge and confidence for self-management of health, and lead to better health outcomes.6-7

This study adds to the literature as a large, randomized controlled trial evaluating the effectiveness of a digital intervention in the field of hypertension and with follow-up for a year. The authors highlight that relatively few studies have been performed that combine self-monitoring with a digitally delivered cointervention, and none has shown a major effect in an adequately powered trial over a year. Results from this study showed that HOME BP, a digital intervention enabling self-management of hypertension, including self-monitoring, titration based on self-monitored BP, lifestyle advice, and behavioral support for patients and health care professionals, resulted in a worthwhile reduction of systolic BP. In addition, this reduction was achieved at modest cost based on the within trial cost effectiveness analysis.

Pages

Recommended Reading

New European guidelines on CVD prevention
Journal of Clinical Outcomes Management
Growing proportion of cardiac arrests in U.S. considered opioid related
Journal of Clinical Outcomes Management
‘Quadpill’ bests monotherapy for initial BP lowering: QUARTET
Journal of Clinical Outcomes Management
Feds slap UPMC, lead cardiothoracic surgeon with fraud lawsuit
Journal of Clinical Outcomes Management
Cavernous gender gap in Medicare payments to cardiologists
Journal of Clinical Outcomes Management
Weight-loss surgery linked to fewer cardiovascular events, more so with RYGB
Journal of Clinical Outcomes Management
Texts boost activity, quality of life in patients with heart failure and diabetes
Journal of Clinical Outcomes Management
COVID vaccine preprint study prompts Twitter outrage
Journal of Clinical Outcomes Management
A new weight loss threshold for T2d remission after bariatric surgery?
Journal of Clinical Outcomes Management
New AHA guidance targets obesity-related hypertension
Journal of Clinical Outcomes Management